Alzheimer’s (START)

Enrolling Now
Study Information

Synaptic Therapy Alzheimer’s Research Trial (START): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer’s Disease over 18 Months

Apply to Participate

If you are interested in participating in this study, please complete the following preliminary qualification form.

We will follow-up with you after we have received your submission.

"*" indicates required fields

General Information

Name*
ZIP / Postal Code*

Preferences

Email Opt-In*
SMS/Text Opt-In*
This field is for validation purposes and should be left unchanged.